Pideka Group Inc. (CIMVF) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, Pideka Group Inc. (CIMVF) es una empresa del sector Healthcare valorada en 0. La acción obtiene una puntuación de 56/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 17 mar 2026Pideka Group Inc. (CIMVF) Resumen de Asistencia Médica y Tuberías
Pideka Group Inc., operating as Ikänik Farms, is an integrated cannabis company focusing on cultivation, production, and distribution in California and Colombia. With a negative P/E ratio of -1.16 and a gross margin of 13.1%, the company competes in the specialty and generic drug manufacturing sector, offering products under the Ikanik, Essentials, Ronen, and Rations brands.
Tesis de Inversión
Pideka Group Inc. (CIMVF) presents a speculative investment opportunity in the cannabis sector, characterized by high growth potential but also significant risks. With a current market capitalization of $0.00B and a negative P/E ratio of -1.16, the company's financial performance is under pressure, as reflected by a profit margin of -2220.5%. The company's gross margin stands at 13.1%. Key value drivers include expansion of its cultivation and production capabilities in Colombia, increased market penetration in California, and development of new cannabis-based products. Growth catalysts include evolving cannabis regulations in key markets and increasing consumer acceptance of cannabis products. However, potential risks include intense competition, regulatory uncertainties, and the company's current financial instability. Investors should carefully consider these factors before investing in CIMVF.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market Cap of $0.00B indicates the company is a micro-cap stock with high growth potential but also higher risk.
- P/E Ratio of -1.16 reflects the company's current lack of profitability, requiring further analysis of its future earnings potential.
- Profit Margin of -2220.5% suggests significant operational challenges and the need for improved cost management.
- Gross Margin of 13.1% indicates the company's ability to generate revenue from sales after accounting for the cost of goods sold, but it needs to be improved.
- Beta of 0.57 suggests the stock is less volatile than the overall market, potentially offering some downside protection.
Competidores y Pares
Fortalezas
- Vertically integrated operations.
- Focus on pharmaceutical-grade cannabinoids.
- Presence in both California and Colombia.
- Established brand portfolio.
Debilidades
- Negative profitability.
- High operating expenses.
- Limited market share.
- Dependence on regulatory approvals.
Catalizadores
- Upcoming: Potential changes in cannabis regulations in key markets.
- Ongoing: Expansion of cultivation and production capabilities in Colombia.
- Ongoing: Increased market penetration in California.
- Ongoing: Development of new cannabis-based products.
Riesgos
- Potential: Intense competition from other cannabis companies.
- Potential: Regulatory uncertainties and changes in cannabis laws.
- Ongoing: The company's current financial instability and negative profitability.
- Potential: Fluctuations in cannabis prices and market demand.
- Potential: Limited access to capital and financing options.
Oportunidades de crecimiento
- Expansion of cultivation and production in Colombia: Colombia offers a favorable environment for cannabis cultivation due to its climate and lower production costs. Pideka Group Inc. can leverage this advantage to increase its production capacity and reduce costs, enhancing its competitiveness in the global cannabis market. The global cannabis market is projected to reach $47 billion by 2025, providing a substantial opportunity for growth. Timeline: Ongoing.
- Increased market penetration in California: California is one of the largest cannabis markets in the United States. Pideka Group Inc. can expand its presence in California by opening new dispensaries, increasing its distribution network, and developing new products tailored to the California market. The California cannabis market is projected to reach $7 billion by 2024. Timeline: Ongoing.
- Development of new cannabis-based products: Pideka Group Inc. can develop new cannabis-based products, such as edibles, beverages, and topicals, to cater to evolving consumer preferences. The market for cannabis-based products is growing rapidly, driven by increasing consumer demand for alternative consumption methods. The global cannabis edibles market is projected to reach $5 billion by 2025. Timeline: Ongoing.
- Strategic partnerships and acquisitions: Pideka Group Inc. can pursue strategic partnerships and acquisitions to expand its market reach, diversify its product portfolio, and gain access to new technologies. The cannabis industry is undergoing consolidation, with larger companies acquiring smaller players to gain scale and market share. Timeline: Ongoing.
- Expansion into international markets: Pideka Group Inc. can expand its operations into other international markets, such as Europe and Latin America, to capitalize on the growing global demand for cannabis products. The European cannabis market is projected to reach $3.9 billion by 2023, presenting a significant opportunity for growth. Timeline: Ongoing.
Oportunidades
- Expansion into new markets.
- Development of new products.
- Strategic partnerships and acquisitions.
- Increasing consumer acceptance of cannabis.
Amenazas
- Intense competition.
- Regulatory uncertainties.
- Fluctuations in cannabis prices.
- Economic downturns.
Ventajas competitivas
- Vertically integrated operations provide control over the supply chain.
- Focus on pharmaceutical-grade cannabinoids differentiates the company from competitors.
- Established presence in both California and Colombia provides access to key markets.
- Brand recognition through the Ikanik, Essentials, Ronen, and Rations brands.
Acerca de CIMVF
Ikänik Farms, Inc., operating as Pideka Group Inc. (CIMVF), is a vertically integrated cannabis company with operations spanning cultivation, production, distribution, and dispensary management. Founded with the vision of becoming a leading provider of pharmaceutical-grade cannabinoids, the company has established a presence in both California and Colombia. Ikänik Farms offers a diverse product portfolio, including pharmaceutical-grade cannabinoids, decarboxylated flower, finished CBD products, and finished ingredient cannabis oil, catering to scientific and commercial markets. These products are marketed under the brands Ikanik, Essentials, Ronen, and Rations. The company's operations in California focus on distribution and dispensary management, leveraging the state's established cannabis market. In Colombia, Ikänik Farms concentrates on cultivation and production, taking advantage of the country's favorable climate and regulatory environment for cannabis cultivation. This dual-market strategy allows the company to serve both domestic and international demand for cannabis products. Pideka Group Inc. is headquartered in Toronto, Canada, reflecting its strategic focus on international cannabis markets and its commitment to regulatory compliance and quality standards. The company aims to differentiate itself through its focus on pharmaceutical-grade products and its integrated supply chain.
Qué hacen
- Cultivates cannabis in Colombia.
- Produces pharmaceutical-grade cannabinoids.
- Manufactures decarboxylated flower.
- Creates finished CBD products.
- Develops finished ingredient cannabis oil.
- Distributes cannabis products in California and Colombia.
- Operates cannabis dispensaries in California.
Modelo de Negocio
- Cultivation and production of cannabis in Colombia.
- Distribution and sale of cannabis products in California and Colombia.
- Branding and marketing of cannabis products under the Ikanik, Essentials, Ronen, and Rations brands.
Contexto de la Industria
Pideka Group Inc. operates within the rapidly evolving cannabis industry, which is experiencing significant growth driven by increasing legalization and acceptance of cannabis for both medical and recreational use. The market is characterized by intense competition, with numerous players vying for market share. Key trends include the development of new cannabis-based products, the expansion of retail dispensaries, and the increasing consolidation of cannabis companies. Pideka Group Inc. aims to differentiate itself through its focus on pharmaceutical-grade products and its integrated supply chain. Competitors include ACNNF (Acreage Holdings Inc.), CBDNF (Charlotte's Web Holdings, Inc.), DLTNF (Delta 9 Cannabis Inc.), EEVVF (EnWave Corporation), and EPWCF (Empower Clinics Inc.).
Clientes Clave
- Scientific researchers requiring pharmaceutical-grade cannabinoids.
- Commercial businesses utilizing cannabis oil as an ingredient.
- Consumers purchasing cannabis products through dispensaries.
- Patients seeking medical cannabis products.
Finanzas
Gráfico e información
Precio de la acción de Pideka Group Inc. (CIMVF): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para CIMVF.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CIMVF.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para CIMVF.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de CIMVF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Borja Sanz De Madrid
CEO
Borja Sanz De Madrid is the Chief Executive Officer of Pideka Group Inc. His background includes experience in international business development and corporate strategy. Prior to joining Pideka Group Inc., he held leadership positions in various multinational companies, focusing on market entry and expansion strategies. He has a strong understanding of the cannabis industry and a track record of driving growth in emerging markets. His expertise includes regulatory compliance, operational efficiency, and strategic partnerships.
Historial: Since becoming CEO, Borja Sanz De Madrid has focused on streamlining operations and expanding the company's presence in key markets. Key achievements include securing strategic partnerships with distributors and increasing production capacity in Colombia. He has also overseen the development of new cannabis-based products and the expansion of the company's dispensary network in California.
Información del mercado OTC de CIMVF
The OTC Other tier represents the lowest tier of the OTC market, indicating that Pideka Group Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Trading on the OTC Other tier carries higher risks compared to exchanges like NYSE or NASDAQ due to the lack of stringent listing requirements and regulatory oversight.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure increases the risk of investing in CIMVF.
- Lower trading volume and wider bid-ask spreads can make it difficult to buy or sell shares.
- Lack of regulatory oversight increases the risk of fraud and manipulation.
- The company's financial stability is uncertain due to its negative profitability.
- The cannabis industry is subject to regulatory changes and uncertainties.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's competitive position in the cannabis market.
- Evaluate the company's regulatory compliance and risk management practices.
- Monitor the company's news releases and investor relations materials.
- Consult with a financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- The company has established operations in both California and Colombia.
- The company has a portfolio of branded cannabis products.
- The company has a CEO with experience in international business development.
- The company is involved in the cultivation, production, and distribution of cannabis.
Acciones de Pideka Group Inc.: Preguntas Clave Respondidas
¿Cuáles son los factores clave para evaluar CIMVF?
Pideka Group Inc. (CIMVF) actualmente tiene una puntuación IA de 56/100, indicando puntuación moderada. Fortaleza clave: Vertically integrated operations.. Riesgo principal a monitorear: Potential: Intense competition from other cannabis companies.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de CIMVF?
CIMVF actualmente puntúa 56/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de CIMVF?
Los precios de CIMVF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre CIMVF?
La cobertura de analistas para CIMVF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en CIMVF?
Las categorías de riesgo para CIMVF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Intense competition from other cannabis companies.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de CIMVF?
La relación P/E para CIMVF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está CIMVF sobrevalorada o infravalorada?
Determinar si Pideka Group Inc. (CIMVF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de CIMVF?
Pideka Group Inc. (CIMVF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data is limited and may not be fully up-to-date.
- Analyst ratings are scarce due to the company's OTC listing.
- The cannabis industry is subject to rapid changes and regulatory uncertainties.